Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
letter
. 2016 Mar;22(3):567–568. doi: 10.3201/eid2203.151701

Wohlfahrtiimonas chitiniclastica Infections in 2 Elderly Patients, Hawaii, USA

Masayuki Nogi 1,2,3,, Matthew J Bankowski 1,2,3, Francis D Pien 1,2,3
PMCID: PMC4766884  PMID: 26889722

To the Editor: We describe 2 cases of Wohlfahrtiimonas chitiniclastica sepsis and skin and soft tissue infections in 2 elderly patients; 1 case was fatal. Both patients lived in poor hygienic conditions in Hawaii, USA.

The first case occurred in a 72-year-old man with history of stroke and deafness. After being unattended for 3 days, he was found unconscious on the floor of his home. He was hypotensive, bradycardic, and hypothermic. Maggots were crawling out of an umbilical wound and were present in a 2 × 3 cm laceration on his right dorsal foot. His leukocyte count was 2.4 × 103 cells/μL with 42% band cells, creatinine level was 2.5 mg/dL, and lactic acid level was 1.8 mg/dL. Aerobic and anaerobic cultures of blood collected at hospital admission grew Escherichia coli and W. chitiniclastica within 12 hours. Initial treatment consisted of intravenous piperacillin/tazobactam (4.5 g every 6 h), intravenous clindamycin (900 mg every 8 h), and intravenous vancomycin (1,000 mg every 12 h). The patient died from septic shock on his second hospital day. W. chitiniclastica was identified by using 16S rRNA sequencing (MicroSeq 500 16S rDNA Bacterial Identification Kit; Applied Biosystems, Foster City, CA, USA) and analyzed by using RipSeq mixed DNA interpretation software (iSentio Ltd., Bergen, Norway). A 100% match with W. chitiniclastica type strain H100 (GenBank accession no. HQ407275) was observed. Antimicrobial drug–susceptibility testing was performed by using a microdilution method (MicroScan Dried Overnight Gram-Negative Panel; Siemens Medical Solutions, Malvern, PA, USA). The isolate was sensitive to all drugs tested, including classes of penicillin, cephalosporin, fluoroquinolone, carbapenem, tetracycline, and aminoglycoside.

The second case occurred in a 69-year-old homeless woman with a history of right hemiparesis from a ruptured cerebral aneurysm. She reported having had sacral pain and painful urination during the week before admission. Physical examination revealed stable vital signs, disheveled appearance, and multiple purulent decubitus ulcers in her sacral area. Her leukocyte count was high (20.9 × 103 cells/μL). Urinalysis revealed pyuria, positive nitrates, and moderate leukocyte esterase, indicative of a urinary tract infection. Two blood cultures and urine culture were obtained at admission. She was given intravenous ceftaroline fosamil (600 mg every 12 h) to treat the urinary tract and decubitus ulcer infections. She then underwent surgical debridement of her decubitus ulcers, where tissue from a deep wound was obtained for aerobic and anaerobic culture. The deep wound culture grew polymicrobial flora that included W. chitiniclastica, Staphylococcus aureus, Aeromonas spp., S. simulans, and Bacteroides fragilis. The anaerobic bottle from both blood cultures grew a gram-negative anaerobic bacillus, Anaerobiospirilum succinicproducens. In addition, Proteus mirabilis was isolated from a urine culture. These culture results prompted a change in the patient’s antimicrobial drug regimen to intravenous meropenem (1 g every 8 h), which the patient received for 12 days. She responded well and was discharged and prescribed oral amoxicillin/clavulanate (875 mg/125 mg every 12 h) for 3 weeks, for what would amount to a 34-day course of antimicrobial treatment since her hospital admission. W. chitiniclastica was identified by using 16S rRNA sequencing (MicroSeq 500 16S rDNA Bacterial Identification Kit). A 100% match with W. chitiniclastica type strain H100 (GenBank accession no. HQ407275) was observed. Antimicrobial drug–susceptibility testing results were the same as those observed for the previously described patient.

W. chitiniclastica is a short, gram-negative, facultative anaerobic, and motile gammaproteobacterium with strong chitinase activity. It was isolated from the homogenated third-stage larvae of the W. magnifica fly (1) (Figure). This fly has been reported as the cause of myiasis in live vertebrates in Spain, France, Hungary, Turkey, Egypt, Iran, and Korea (2); its distribution is known to be progressively expanding, in part because of its broad adaptation capacities. Reported cases of human bacteremia have been mainly from Europe and South America; patients included a 60-year-old homeless woman in southeastern France (3), a 70-year-old homeless man with alcoholism in Argentina (4), and an 82-year-old woman in the United Kingdom (5). A skin and soft tissue infection was reported in a child with orofacial gangrene (noma) in Niger (6), and an osteomyelitis case was reported in India (7). The northernmost region from which a case has been reported is Estonia, where a 64-year-old man with chronic foot gangrene was coinfected with W. chitiniclastica and Myroides odoratimimus (8). Cases from the United States include septicemia in a deer in Michigan (9) and a leg wound infection in a 26-year-old man in New York (10).

Figure.

Figure

Adult Wohlfahrtiimonas magnifica fly. Image courtesy of Joaquim Alves Gaspar, Wikimedia Commons.

For the 2 patients in Hawaii, maggots were not collected, and we could not identify the specific fly species. In the first patient, W. chitiniclastica was clinically relevant because it was isolated from blood culture and maggots were observed in his wound. However, the coexisting E. coli infection may have played a critical role in the patient’s death. The second case was nonfatal, and we cannot determine the clinical relevance of W. chitiniclastica because it was isolated from a polymicrobial wound in which no maggots were observed and because A. succinicproducens was isolated from blood culture. Even so, these reports should help increase awareness of this specific type of infection related to myiasis in homeless and hygiene-deficient patients in the United States.

Acknowledgment

We are grateful to the clinical and molecular microbiology staff at Diagnostic Laboratory Services, Inc. for their diagnostic microbiology expertise in investigating these cases.

Footnotes

Suggested citation for this article: Nogi M, Bankowski MJ, Pien FD. Wohlfahrtiimonas chitiniclastica in 2 elderly patients, Hawaii [letter]. Emerg Infect Dis. 2016 Mar [date cited]. http://dx.doi.org/10.3201/eid2203.151701

References

  • 1.Tóth EM, Schumann P, Borsodi AK, Kéki Z, Kovács AL, Márialigeti K. Wohlfahrtiimonas chitiniclastica gen. nov., sp. nov., a new gammaproteobacterium isolated from Wohlfahrtia magnifica (Diptera: Sarcophagidae). Int J Syst Evol Microbiol. 2008;58:976–81 . 10.1099/ijs.0.65324-0 [DOI] [PubMed] [Google Scholar]
  • 2.Hall MJR, Adams ZJO, Wyatt NP, Testa JM, Edge W, Nikolausz M, et al. Morphological and mitochondrial DNA characters for identification and phylogenetic analysis of the myiasis-causing flesh fly Wohlfahrtia magnifica and its relatives, with a description of Wohlfahrtia monegrosensis sp. n. Wyatt & Hall. Med Vet Entomol. 2009;23(Suppl 1):59–71. 10.1111/j.1365-2915.2008.00779.x [DOI] [PubMed] [Google Scholar]
  • 3.Rebaudet S, Genot S, Renvoise A, Fournier PE, Stein A. Wohlfahrtiimonas chitiniclastica bacteremia in homeless woman. Emerg Infect Dis. 2009;15:985–7. 10.3201/eid1506.080232 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Almuzara MN, Palombarani S, Tuduri A, Figueroa S, Gianecini A, Sabater L, et al. First case of fulminant sepsis due to Wohlfahrtiimonas chitiniclastica. J Clin Microbiol. 2011;49:2333–5. 10.1128/JCM.00001-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Campisi L, Mahobia N, Clayton JJ. Wohlfahrtiimonas chitiniclastica bacteremia associated with myiasis, United Kingdom. Emerg Infect Dis. 2015;21:1068–9. 10.3201/eid2106.140007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bolivar I, Whiteson K, Stadelmann B, Baratti-Mayer D, Gizard Y, Mombelli A, et al. Bacterial diversity in oral samples of children in Niger with acute noma, acute necrotizing gingivitis, and healthy controls. PLoS Negl Trop Dis. 2012;6:e1556. [DOI] [PMC free article] [PubMed]
  • 7.Suryalatha K, John J, Thomas S. Wohlfahrtiimonas chitiniclastica-associated osteomyelitis: a rare case report. Future Microbiol. 2015;10:1107–9. 10.2217/fmb.15.44 [DOI] [PubMed] [Google Scholar]
  • 8.Kõljalg S, Telling K, Huik K, Murruste M, Saarevet V, Pauskar M, et al. First report of Wohlfahrtiimonas chitiniclastica from soft tissue and bone infection at an unusually high northern latitude. Folia Microbiol (Praha). 2015;60:155–8. 10.1007/s12223-014-0355-x [DOI] [PubMed] [Google Scholar]
  • 9.Thaiwong T, Kettler NM, Lim A, Dirkse H, Kiupel M. First report of emerging zoonotic pathogen Wohlfahrtiimonas chitiniclastica in the United States. J Clin Microbiol. 2014;52:2245–7. 10.1128/JCM.00382-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.de Dios A, Jacob S, Tayal A, Fisher MA, Dingle TC, Hamula CL. First report of Wohlfahrtiimonas chitiniclastica isolation from a patient with cellulitis in the United States. J Clin Microbiol. 2015;53:3942–4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES